Portfolio company
Discovery
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Animol Discovery develops a biopharmaceutical platform for small-molecule drug discovery to provide medicines for companion and production animals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Animol Discovery
This biopharmaceutical company develops small molecule medicines for companion and production animals using artificial intelligence and DNA-encoded library technologies.
Animab
Animab develops oral monoclonal antibody products for livestock farmers to control gastrointestinal pathogens and improve animal health without using antibiotics.
Okapi Sciences
The company develops antiviral drugs for veterinary applications to treat viral infections in pets and livestock.
Avicenna Biosciences
The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.
BiomEdit
BiomEdit develops microbiome-derived probiotics and microbial medicines to improve the health and productivity of livestock and pets for the animal health industry.
PetMedix
PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.
ScoutBio
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
Insamo
The company develops a platform to discover orally available cyclic peptides for pharmaceutical organisations seeking alternatives to injectable biologic medicines.